Gravity Analytica

Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference

AVRO 11.26.2024

SERA-AI Powered Highlights

Date of Upcoming Event:2024-12-03

Name of Upcoming Event:Piper Sandler 36th Annual Healthcare Conference

Full Press Release SEC Filings Our AVRO Tweets

About Gravity Analytica

Recent Filings

WATERTOWN, Mass.,Nov. 26, 2024(GLOBE NEWSWIRE) --Tectonic Therapeutic, Inc.(NASDAQ: TECX) (Tectonic), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced thatAlise Reicin, MD, President and Chief Executive Officer, will present at the Piper Sandler 36^thAnnual Healthcare Conference being held inNew YorkonDecember 3-5, 2024.

Piper Sandler 36^thAnnual Healthcare Conference details:

Meetings:	Presentation and one-on-one meetings
Presentation Date:	Tuesday, December 3^rd, 2024
Presentation Time:	12:30 PM ET
Presenter:	Alise Reicin, MD, President and Chief Executive Officer
Webcast:	Link

For more information regarding one-on-one meetings, please contact your Piper Sandler representative.

The live webcast can also be accessed under “Events & Presentations” on the Investors section of the Tectonic website atwww.tectonictx.com. Once the conference has concluded, a replay of the webcast will be available on the Company’s website for approximately 90 days.

About Tectonic

Tectonicis a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs). Leveraging its proprietary GEODeTM (GPCRs Engineered for Optimal Discovery) technology platform, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in Watertown,Massachusetts. For more information, please visitwww.tectonictx.comand follow onLinkedIn.

Investors:Dan FerryLifeSci Advisorsdaniel@lifesciadvisors.com(617) 430-7576Media:Kathryn MorrisThe Yates Networkkathryn@theyatesnetwork.com(914) 204-6412

Source: Tectonic Therapeutic

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com